Bristol-Myers Squibb (BMY)
Healthcare • Drug Manufacturers - General
StockNYSEUnited StatesUS1101221083
62.45 USD
+0.21% today Updated 13 Nov 2026 16:03
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Bristol-Myers Squibb, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:03. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
04 Feb 2027
in 83 days · 08:00 · estimate 1.50
Last results
1.35 vs 1.17 estimated
29 Oct 2026 · Beat +15.2%
Beat the estimate
11 of 12
0 missed · 1 in line · 10 beats in a row
Average surprise
+15.6%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 04 Feb 2027 08:00 | 1.50 | — | — | Upcoming |
| 29 Oct 2026 07:00 | 1.17 | 1.35 | +15.2% | Beat |
| 30 Jul 2026 07:00 | 1.60 | 2.04 | +27.7% | Beat |
| 30 Apr 2026 07:00 | 1.42 | 1.58 | +11.2% | Beat |
| 05 Feb 2026 07:00 | 1.20 | 1.26 | +4.6% | Beat |
| 30 Oct 2025 07:00 | 1.52 | 1.63 | +7.6% | Beat |
| 31 Jul 2025 07:00 | 1.10 | 1.46 | +32.6% | Beat |
| 24 Apr 2025 07:00 | 1.50 | 1.80 | +19.9% | Beat |
| 06 Feb 2025 06:00 | 1.47 | 1.67 | +13.8% | Beat |
| 31 Oct 2024 06:00 | 1.50 | 1.80 | +20.0% | Beat |
| 26 Jul 2024 06:00 | 1.63 | 2.07 | +27.4% | Beat |
| 25 Apr 2024 06:00 | -4.40 | -4.40 | -0.1% | In line |
| 02 Feb 2024 06:00 | 1.58 | 1.70 | +7.8% | Beat |
| 26 Oct 2023 06:00 | 1.77 | 2.00 | +13.0% | Beat |
| 27 Jul 2023 07:00 | 1.99 | 1.75 | -12.0% | Miss |
| 27 Apr 2023 06:00 | 1.97 | 2.05 | +3.9% | Beat |
| 02 Feb 2023 06:00 | 1.73 | 1.82 | +5.2% | Beat |
| 25 Oct 2022 19:00 | 1.83 | 1.99 | +8.5% | Beat |
| 27 Jul 2022 06:00 | 1.80 | 1.93 | +7.3% | Beat |
| 29 Apr 2022 06:00 | 1.90 | 1.96 | +3.3% | Beat |
| 04 Feb 2022 06:00 | 1.80 | 1.83 | +1.7% | Beat |
| 27 Oct 2021 06:00 | 1.92 | 2.00 | +4.3% | Beat |
| 28 Jul 2021 06:00 | 1.90 | 1.93 | +1.8% | Beat |
| 29 Apr 2021 06:00 | 1.81 | 1.74 | -3.9% | Miss |
| 04 Feb 2021 06:00 | 1.42 | 1.46 | +3.1% | Beat |
| 05 Nov 2020 06:00 | 1.49 | 1.63 | +9.3% | Beat |
| 06 Aug 2020 06:00 | 1.48 | 1.63 | +10.2% | Beat |
| 07 May 2020 07:00 | 1.45 | 1.72 | +18.8% | Beat |
| 06 Feb 2020 08:00 | 1.16 | 1.22 | +5.2% | Beat |
| 31 Oct 2019 06:00 | 1.07 | 1.17 | +9.4% | Beat |
| 25 Jul 2019 06:00 | 1.06 | 1.18 | +10.8% | Beat |
| 25 Apr 2019 06:00 | 1.08 | 1.10 | +1.5% | Beat |
| 24 Jan 2019 06:00 | 0.85 | 0.94 | +10.9% | Beat |
| 25 Oct 2018 06:00 | 0.91 | 1.09 | +19.4% | Beat |
| 26 Jul 2018 06:00 | 0.87 | 1.01 | +15.5% | Beat |
| 26 Apr 2018 06:00 | 0.85 | 0.94 | +10.9% | Beat |
| 05 Feb 2018 06:00 | 0.67 | 0.68 | +1.2% | Beat |
| 26 Oct 2017 06:00 | 0.77 | 0.75 | -2.8% | Miss |
| 27 Jul 2017 06:00 | 0.73 | 0.74 | +0.8% | In line |
| 27 Apr 2017 06:00 | 0.74 | 0.84 | +13.6% | Beat |
| 26 Jan 2017 06:00 | 0.66 | 0.63 | -5.0% | Miss |
| 27 Oct 2016 06:00 | 0.65 | 0.77 | +17.9% | Beat |
| 28 Jul 2016 06:00 | 0.66 | 0.69 | +3.8% | Beat |
| 28 Apr 2016 06:00 | 0.65 | 0.74 | +14.2% | Beat |
| 28 Jan 2016 06:00 | 0.28 | 0.38 | +34.3% | Beat |
| 27 Oct 2015 06:00 | 0.35 | 0.39 | +11.4% | Beat |
| 23 Jul 2015 10:00 | 0.36 | 0.53 | +47.1% | Beat |
| 28 Apr 2015 07:00 | 0.51 | 0.71 | +40.2% | Beat |
| 27 Jan 2015 07:00 | 0.41 | 0.46 | +13.3% | Beat |
| 24 Oct 2014 07:00 | 0.42 | 0.45 | +7.4% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 48.2B | -0.2% | 7.1B | 14.6% | 3.46 | +178.5% | 12.8B |
| 2024 | 48.3B | +7.3% | -8.9B | -18.5% | -4.41 | -214.2% | 13.9B |
| 2023 | 45B | -2.5% | 8B | 17.8% | 3.86 | +30.8% | 12.7B |
| 2022 | 46.2B | — | 6.3B | 13.7% | 2.95 | — | 11.9B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 62.88 | 64.12 | 61.30 | 62.32 | +0.29% | 31,099,000 | |
| 02 Nov 2026 – 06 Nov 2026 | 62.45 | 65.54 | 61.32 | 62.14 | -0.54% | 54,075,200 | |
| 26 Oct 2026 – 30 Oct 2026 | 61.39 | 64.05 | 60.00 | 62.48 | +1.63% | 50,461,900 | |
| 19 Oct 2026 – 23 Oct 2026 | 59.40 | 63.59 | 58.44 | 61.48 | +2.90% | 57,398,300 | |
| 12 Oct 2026 – 16 Oct 2026 | 60.11 | 62.25 | 56.15 | 59.75 | +1.07% | 81,091,400 | |
| 05 Oct 2026 – 09 Oct 2026 | 59.89 | 60.15 | 58.33 | 59.12 | -3.32% | 62,537,800 | |
| 28 Sep 2026 – 02 Oct 2026 | 62.77 | 64.13 | 60.24 | 61.15 | -2.72% | 66,423,400 | 0.6300 |
| 21 Sep 2026 – 25 Sep 2026 | 63.09 | 63.40 | 60.60 | 62.86 | -0.32% | 63,490,500 | |
| 14 Sep 2026 – 18 Sep 2026 | 64.59 | 65.29 | 62.19 | 63.06 | -0.91% | 75,408,300 | |
| 08 Sep 2026 – 11 Sep 2026 | 65.66 | 65.89 | 63.27 | 63.64 | -4.76% | 29,645,800 | |
| 253 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Advanced Therapy Medicinal Products - Global Strategic Business Report: Capitalize on 11.8% CAGR to Secure $25.4B by 2030 as Novartis, Gilead, Bristol-Myers Squibb and Roche Compete (opens in a new tab) 11 Nov 2026 14:27
- Bristol Myers Squibb (BMY) Reports 56 Week Pediatric Phase 3 Camzyos Data (opens in a new tab) Simply Wall St. · 09 Nov 2026 17:18
- Bristol-Myers Squibb Says Camzyos Shows Sustained Efficacy in Phase 3 Pediatric Trial (opens in a new tab) MT Newswires · 06 Nov 2026 21:56
- Bristol Myers Squibb (BMY) Expands Neuroscience Push With Multi Year AI Alliance (opens in a new tab) Simply Wall St. · 06 Nov 2026 09:14
- Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Rally Already Priced In? (opens in a new tab) Simply Wall St. · 05 Nov 2026 16:17
- Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know (opens in a new tab) Zacks · 04 Nov 2026 13:00
- Bristol-Myers Squibb (NYSE:BMY) Breakout Setup Backed by Technical Strength (opens in a new tab) ChartMill · 04 Nov 2026 12:40
- BMY Q3 deep dive: pipeline advances offset margin pressure as guidance shifts (opens in a new tab) StockStory · 02 Nov 2026 21:57
- 5 must-read analyst questions from Bristol-Myers Squibb’s Q3 earnings call (opens in a new tab) StockStory · 02 Nov 2026 14:29
- BMY Up 3% Post Q3 Earnings: Should You Buy, Sell or Hold the Stock? (opens in a new tab) 02 Nov 2026 12:45
- 43 ETFs Add to Bristol-Myers Squibb (BMY) on Oct. 29 (opens in a new tab) 02 Nov 2026 11:01
- Bristol Myers Squibb (BMY) Reports Positive Phase 2 Pumitamig Lung Cancer Data (opens in a new tab) 31 Oct 2026 12:12
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 62.32 USD
- Market cap
- 127.4B
- Dividend yield
- 4.04%
- 5-year average yield
- 3.86%
- Payout ratio
- 56%
- Last dividend
- 0.6300 USD · 02 Oct 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 02 Oct 2026 | 0.6300 USD |
| 02 Jul 2026 | 0.6300 USD |
| 02 Apr 2026 | 0.6300 USD |
| 02 Jan 2026 | 0.6300 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow BMY and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.